STOCKHOLM, Oct. 27, 2022 /PRNewswire/ Swedish Orphan Biovitrum AB (publ) (Sobi) today announced its report for the third quarter of 2022 July - September 2022 Total revenue SEK
/PRNewswire/ Swedish Orphan Biovitrum AB (publ) (SobiĀ®) today announced its report for the third quarter of 2022 July - September 2022 Total revenue SEK.
STOCKHOLM, Sept. 16, 2022 /PRNewswire/ Sobi and ADC Therapeutics SA today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted